A review of evolving dialysis catheter technologies

Seminars in Interventional Radiology

Volumn 26, Issue 2, 2009, Pages 106-114

  Knuttinen, Martha Grace ^a   Bobra, Sonia ^a   Hardman, Julian ^a   Gaba , Ron C ^a   Bui, James T ^a   Owens, Charles A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Catheters; Dialysis; End stage renal disease; Tunneled catheters

Indexed keywords

EID: 68149179243     PISSN: 07399529     EISSN: 10988963     Source Type: Journal    
DOI: 10.1055/s-0029-1222453     Document Type: Article

References (51)

1. Anonymous. III. NKF-K/DOQI clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis 2001;37 (1, Suppl 1):S137-S181
2. Tokars JI, Frank M, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 2002;15(3):162-171
3. U.S. Renal Data System. USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008
4. Willms L, Vercaigne LM. Does warfarin safely prevent clotting of hemodialysis catheters? A review of efficacy and safety Semin Dial 2008;21(1):71-77
5. Watnick S, Stooksbury M, Winter R, Riscoe M, Cohen DM. White thrombus formation in blood tubing lines in a chronic hemodialysis unit. Clin J Am Soc Nephrol 2008;3(2):382-386
6. Lénárd L, Szabados S, Imre J, et al. [Vena cava superior syndrome: surgical treatment of the thrombosis of the superior vena cava after implantation of a hemodialysis cathetera case report and review of the literature]. Orv Hetil 2008;149(1):29-34
7. Solomon DD, Arnold WL, Martin ND, Lentz DJ. An in vivo method for the evaluation of catheter thrombogenicity. J Biomed Mater Res 1987;21(1):43-57
8. Sherertz RJ, Carruth WA, Marosok RD, Espeland MA, Johnson RA, Solomon DD. Contribution of vascular catheter material to the pathogenesis of infection: the enhanced risk of silicone in vivo. J Biomed Mater Res 1995;29(5):635-645
9. Tal MG, Ni N. Selecting optimal hemodialysis catheters: material, design, advanced features, and preferences. Tech Vasc Interv Radiol 2008;11(3):186-191
10. Atherikul K, Schwab SJ, Conlon PJ. Adequacy of haemo-dialysis with cuffed central-vein catheters. Nephrol Dial Transplant 1998;13(3):745-749
11. Mickley V. Central venous catheters: many questions, few answers. Nephrol Dial Transplant 2002;17(8):1368-1373
12. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBAC-DIAL: multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998;9(5):869-876
13. Nielsen J, Ladefoged SD, Kolmos HJ. Dialysis catheter-related septicaemiamdashfocus on Staphylococcus aureus septicaemia. Nephrol Dial Transplant 1998;13(11):2847-2852
14. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997;127(4):275-280
15. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 2001;60(4):1443-1451
16. Hung KY, Tsai TJ, Yen CJ, Yen TS. Infection associated with double lumen catheterization for temporary haemodial-ysis: experience of 168 cases. Nephrol Dial Transplant 1995; 10(2):247-251
17. McCarthy MC, Shives JK, Robison RJ, Broadie TA. Prospective evaluation of single and triple lumen catheters in total parenteral nutrition. JPEN J Parenter Enteral Nutr 1987;11:259-262
18. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997;127(4):257-266
19. Greenfeld JI, Sampath L, Popilskis SJ, Brunnert SR, Stylianos S, Modak S. Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine. Crit Care Med 1995;23(5):894-900
20. Schwab SJ, Beathard G. The hemodialysis catheter conundrum: hate living with them, but can't live without them. Kidney Int 1999;56(1):1-17
21. Fan PY. Acute vascular access: new advances. Adv Ren Replace Ther 1994;1(2):90-98
22. Schwab SJ, Buller GL, McCann RL, Bollinger RR, Stickel DL. Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use. Am J Kidney Dis 1988;11(2): 166-169
23. Twardowski Z. High dose intradialytic urokinase to restore patency of permanent central vein hemodialysis catheters. Am J Kidney Dis 1998;31(5):841-847
24. Dryden MS, Samson A, Ludlam HA, Wing AJ, Phillips I. Infective complications associated with the use of the Quinton 'Permcath' for long-term central vascular access in haemodialysis. J Hosp Infect 1991;19(4):257-262
25. Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: prospective randomized multicenter trial. Am J Med 1988; 85(3):307-314
26. Flowers RH III, Schwenzer KJ, Kopel RF, Fisch MJ, Tucker SI, Farr BM. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. JAMA 1989;261(6):878-883
27. Trerotola SO, Johnson MS, Shah H, et al. Tunneled hemodialysis catheters: use of a silver-coated catheter for prevention of infectionmdasha randomized study. Radiology 1998;207(2):491-496
28. Bambauer R, Mestres P, Schiel R, Schneidewind-Muller JM, Bambauer S, Sioshansi P. Large bore catheters with surface treatments versus untreated catheters for blood access. J Vasc Access 2001;2(3):97-105
29. Lau CE. Transparent and gauze dressings and their effect on infection rates of central venous catheters: review of past and current literature. J Intraven Nurs 1996;19(5):240-245
30. James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn B; RAlberta Kidney Disease Network. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 2008;148(8): 596-605
31. Dialysis Outcomes Quality Initiative (DOQI), National Kidney Foundation. Clinical Practice Guidelines for Vascular Access
32. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008;47(1):83-93
33. Silva J, Teixeira EC, Baptista A, Ramos A, Ponce P. Catheter-related bactermia in hemodialysis: which preventive measures to take? Nephron Clin Pract 2008;110(4):c251- c257
34. Onder AM, Chandar J, Simon N, et al. Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks. Pediatr Nephrol 2008;23(3):457-464
35. Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I. Rifampicin-impregnated central venous catheters: meta-analysis of randomized controlled trials. J Antimicrob Chemother 2007;59(3):359-369
36. Halton K, Graves N. Economic evaluation and catheter-related bloodstream infections. Emerg Infect Dis 2007;13(6): 815-823
37. Lumsden A. A unique combination technology of ePTFE and proprietary end-point covalent bonding of heparin for lower extremity revascularization: the GORE PROPATEN vascular graft. Vasc Dis Manag 2007;4(Suppl. B):11B-14B
38. Jain G, Allon M, Maya I. Retrospective comparison of heparin-coated and non-coated tunneled dialysis catheters. ASN 2008; Renal week abstract presentation
39. Trerotola SO, Shah H, Johnson M, et al. Randomized comparison of high-flow versus conventional hemodialysis catheters. J Vasc Interv Radiol 1999;10(8):1032-1038
40. Warren SE, O'Connor DT, Steinberg SM. Recirculation: uremic syndrome complicating the use of prosthetic arterio-venous fistulas for hemodialysis. J Dial 1978;2(3):251-259
41. Senécal L, Saint-Sauveur E, Leblanc M. Blood flow and recirculation rates in tunneled hemodialysis catheters. ASAIO J 2004;50(1):94-97
42. O'Dwyer H, Fotheringham T, O'Kelly P, et al. A prospective comparison of two types of tunneled hemodialysis catheters: the Ash Split versus the PermCath. Cardiovasc Intervent Radiol 2005;28(1):23-29
43. Van Ha T, Santeler S, Lorenz J, et al. Comparison between the split-tip catheter and non split-tip catheter for hemo-dialysis. J Vasc Interv Radiol 2007;18(suppl 1):S45
44. Tal MG, Peixoto AJ, Crowley ST, Denbow N, Eliseo D, Pollak J. Comparison of side hole versus non side hole high flow hemodialysis catheters. Hemodial Int 2006;10(1):63-67
45. Fuchs S, Pollak A, Gilon D. Central venous catheter mechanical irritation of the right atrial free Wall:A cause for thrombus formation. Cardiology 1999;91(3): 169-172
46. Ross J. Optimizing catheter tip positioning. Endovasc Today 2003;2:32-34
47. Davanzo WJ. Efficacy and safety of a retrograde tunneled hemodialysis catheter: 6-month clinical experience with the Cannon Catheter chronic hemodialysis catheter. J Vasc Access 2005;6(1):38-44
48. Tal MG. Comparison of recirculation percentage of the palindrome catheter and standard hemodialysis catheters in a swine model. J Vasc Interv Radiol 2005;16(9):1237-1240
49. Spector M, Mojibian H, Eliseo D, et al. Clinical outcome of the Tal Palindrome chronic hemodialysis catheter: single institution experience. J Vasc Interv Radiol 2008;19(10):1434- 1438
50. Tokars JI, Finelli L, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2001. Semin Dial 2004;17(4):310-319
51. Allon M. Dialysis catheter-related bacteremia: Treatment and prophylaxis. Am J Kidney Dis 2004;44(5):779-791